Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease

BACKGROUND: Synuclein gamma (SNCG) expression is associated with advanced disease and chemoresistance in multiple solid tumors. Our goal was to determine if SNCG protein expression in ovarian cancer was correlated with clinicopathologic variables and patient outcomes. METHODS: Tissue microarrays fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Strohl, Anna, Mori, Kristina, Akers, Stacey, Bshara, Wiam, Buttin, Barbara, Frederick, Peter J., Helenowski, Irene B., Morrison, Carl D, Odunsi, Kunle, Schink, Julian C., Scholtens, Denise M., Wei, Jian-Jun, Kim, J. Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094138/
https://www.ncbi.nlm.nih.gov/pubmed/27809878
http://dx.doi.org/10.1186/s13048-016-0281-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094138/
https://www.ncbi.nlm.nih.gov/pubmed/27809878
http://dx.doi.org/10.1186/s13048-016-0281-4

Ejemplares similares